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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S460strengthening program. Thus, a patient’s health status should not be a
barrier for joining exercise programs. Further research is however
required due to the low sample size of our study.
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DEVELOPMENT OF COMORBIDITY-ADAPTED EXERCISE PROTOCOLS
FOR PATIENTS WITH KNEE OSTEOARTHRITIS
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Purpose: The purpose of this study was to develop comorbidity-
adapted exercise protocols for patients with knee OA and comorbidity.
Method: Several steps were undertaken to develop comorbidity-
adapted protocols: selection of highly prevalent comorbidities in OA, a
literature search to identify restrictions and contraindications for
exercise therapy for the various comorbid diseases, consultation of
experts on each comorbid disease, and ﬁeld testing of the protocol in 11
patients with knee OA and comorbidity.
Results: Based on literature and expert opinion, comorbidity-adapted
protocols were developed for highly prevalent comorbidities in OA.
Field testing showed that the protocols provided guidance in clinical
decision making in both the diagnostic and the treatment phase.
Because of overlap, the number of exercise protocols could be reduced
to three: one for physiological adaptations (coronary disease, heart
failure, diabetes type 2, chronic obstructive pulmonary diseases, obe-
sity), one for behavioural adaptations (chronic a-speciﬁc pain, chronic
low back pain, depression), and one for environmental adaptations
(visual or hearing impairments). Evaluation of patient outcome after
treatment showed signiﬁcant (p < 0.05) and clinically relevant
improvements in activity limitations and pain.
Conclusion: Comorbidity-adapted exercise protocols for patients with
knee OA were developed, providing guidance in clinical reasoning with
regard to diagnostics and treatment. To evaluate the effectiveness of
treatment in line with our protocols, a randomized clinical trial should
be performed.
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A PILOT RANDOMIZED CONTROL TRIAL OF AEROBIC CYCLING
BEFORE TOTAL KNEE ARTHROPLASTY
M. Kennedy. Sport For Life Centre, Sport MB, Winnipeg, MB, Canada
Purpose: The main purpose of the study was to determine if a full trial
of an aerobic cycling program for pre TKA (total knee arthroplasty)
patients was feasible, by assessing recruitment, safety, ability to cycle,
program adherence and aerobic beneﬁt. Secondary objectives were to
estimate sample size for a future full trial and conduct an exploratory
assessment for change in outcome measures (pain, physical function,
quality of life) from pre to post intervention to post surgery.
Methods: The trial was a pilot study with a prospective, randomized
control design. In order to be eligible for the study, patients had tomeet
the following inclusion criteria: have a primary diagnosis of OA of the
knee and be on awaiting list for TKA in the Calgary Health Region, agree
to attend multiple ﬁtness assessments and a thrice per week, on-site
cycling program over 10 weeks before surgery. Patients that were
randomized to the exercise group enrolled in an aerobic cycling program
to attend three cycling sessions per week over 10 weeks before their
surgical date. Each of the cycling sessions was 30 minutes in duration,
with 5minutes used for awarm-up period at the start and 5minutes as a
cool-downperiod at the 25minutemark. Themiddle 20minuteswas an
aerobic exercise period where patients cycled at an intensity that could
improve cardiorespiratoryﬁtness (70-85% of their heart ratemaximum).
Results: A total of 21 pre TKA patients (12 exercise group, 9 control
group) were enrolled in the study. Therewere no statistically signiﬁcant
differences in the baseline demographics, baseline questionnaires or
VO2 max bike results, between the exercise and control groups.The percentage recruited was 8.3% (21/254). The ineligible patients (n¼
295), had a mean age of 67.8 (9.7) and 61% female. The mean age of
declined eligible patients (n¼ 233) was 64.7(8.4) and 54%were females.
Only 1/9 patients in the control groupwas unable to complete their post
intervention submaximal bike test due to knee pain. For patients in the
exercise group, therewere no adverse events due to the cycling sessions
that caused patients to cease cycling or seek medical attention.
Pacing in the cycling sessions was an initial problem in 3/12 exercise
group patients who needed the ﬁrst three to seven sessions to achieve
the required intensity of the exercise program. A total of 38/360 ses-
sions were missed amongst the 12 participants with an overall
attendance rate of 89%.
A paired t test demonstrated a statistically signiﬁcant improvement
in VO2 max for the exercise group from pre to post intervention.
There was no difference in mean V02 max between groups from pre
to post intervention (post mean VO2max, E:25.36.30, C:
23.911.06, p ¼ .754).
Repeated measures ANOVA revealed a signiﬁcant change in mean
WOMAC pain (F(2,31)¼10.26, p  .001) and physical function
(F(2,31)¼11.17, p  .001) scores and SF-36 pcs score (F(2,30)¼5.53, p
¼ .009) over time but no group effect. Further assessment revealed a
signiﬁcant improvement in these scores from pre surgery to three
months post TKA (WOMAC subscales, p  .001, SF-36, p ¼ .004).
Although the difference in mean WOMAC physical function
scores between the exercise and control group widened (by 7 points)
from pre to post intervention, this change was not statistically
signiﬁcant.
Conclusions: In this study, it was demonstrated that patients without
heart disease and younger than age 80, can safely undertake an aerobic
cycling program before TKA surgery. If severe knee OA patients can
tolerate aerobic cycling, then this mode of exercise has potential to
assist in reduction of weight and improvement of overall health and
well-being. Further exploration with a larger sample size, possibly in a
multi-centre trial, would be necessary to determine possible pain and
physical function beneﬁts from aerobic cycling, before or after knee
replacement surgery.
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INCREASED NUMBER OF SUBJECTS WITH ELEVATED LEVELS OF
BLOOD GLUCOSE (HBA1C) AFTER PROLONGED GLUCOSAMINE
USAGE AMONG OVERWEIGHT AND OBESE WOMEN
J. Runhaar, J. Damen, M. van Middelkoop, S.M. Bierma-Zeinstra.
Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: In a recent systematic review, negative effects of prolonged
glucosamine usage on glucose metabolism were more likely among
subjects with impaired insulin resistance or glucose tolerance. Despite
this, glucosamine is recommended for the management of osteo-
arthritis (OA) in international guidelines and is freely available over the
counter. The objective of the present study was to evaluate the effect of
a 2.5 years placebo controlled intervention with oral crystalline glu-
cosamine sulphate on HbA1c levels in middle-aged women with a BMI
 27 kg/m2 and therefore already at increased risk for impaired glucose
tolerance.
Methods: Data from the ﬁrst preventive RCT in OA (the PROOF
study) were used. In total, 407 women between 50 and 60 years,
with a BMI  27 kg/m2, without clinical and radiographic knee OA
at baseline were randomized over oral crystalline glucosamine
sulphate and placebo. At baseline, 1 year, and 2.5 years, HbA1c level
was determined in all subjects. Using restricted maximum like-
lihood methods, the effect of glucosamine usage on HbA1c level
throughout the follow-up period was determined in all subjects.
Thereafter, analyses were rerun for subjects with and without ele-
vated HbA1c level ( 42 mmol/mol) at baseline. These analyses
were adjusted for possible covariates (age, BMI, physical activity
level at baseline and change over 30 months, change in waist cir-
cumference, and season of baseline measurement). Finally, the risk
of attaining an elevated level of HbA1c ( 42 mmol/mol) after 2.5
years was determined for the glucosamine group relative to the
placebo group, additionally adjusted for having an elevated level of
HbA1c at baseline.
Results: At baseline mean age of the 407 included women was 55.7 
3.2 years and mean BMI was 32.4  4.3 kg/m2. HbA1c levels were
Mean HbA1c levels during follow-up for subjects with normal and elevated HbA1c level at baseline
Normal baseline HbA1c
(< 42 mmol/mol)
Elevated baseline HbA1c
( 42 mmol/mol)
Placebo Glucosamine Placebo Glucosamine
Baseline N (%) 150 (74%) 156 (76%) 43 (21%) 32 (16%)
HbA1c (mmol/mol) 36.7  2.9 37.1  2.8 50.6  11.1 51.6  16.8
1 year N (%) 124 (66%) 129 (63%) 36 (18%) 29 (14%)
HbA1c (mmol/mol) 37.2  2.8 37.8  3.0 48.1  9.9 48.9  12.9
2.5 years N (%) 131 (71%) 136 (66%) 34 (17%) 26 (13%)
HbA1c (mmol/mol) 37.3  2.8 37.8  3.7 48.6  12.5 50.2  11.8
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after 2.5 years. The glucosamine intervention had a non-signiﬁcant
effect on mean HbA1c level over 2.5 years, when analysed among all
subjects (p ¼ 0.94), and in subjects with a normal (p ¼ 0.60) or elevated
(p ¼ 0.82) HbA1c level at baseline (see table for stratiﬁed mean HbA1c
values over the follow-up period). However, compared to placebo,
subjects randomized to glucosamine sulphate had a signiﬁcantly
increased risk for attaining an elevated HbA1c level at follow-up (odds
ratio 2.81 [95% CI 1.12 - 7.04]).
Conclusions: A 2.5 year oral glucosamine sulphate intervention did not
affect mean HbA1c levels in overweight and obese women, but did lead
to signiﬁcant more womenwith increased levels of HbA1c ( 42 mmol/
mol). This HbA1c level is known to put people at ‘high risk for devel-
oping diabetes’. Long-term follow-up should demonstrate whether
these women will indeed develop diabetes at a higher rate and thus,
whether this should be considered as a true side effect of glucosamine
within this population.
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STRONTIUM RANELATE DECREASES THE NUMBER OF RAPID
RADIOLOGICAL PROGRESSORS FROM THE FIRST YEAR IN SEKOIA
STUDY
X. Chevalier y, P. Richette z, O. Bruyere x, R. Chapurlat k, C. Cooper {,
J. Reginster x. yHosp. Henri Mondor, Creteil, Fraznce; zHosp. Lariboisiere,
Universite Paris VII, Paris, France; xDept. of Publ. Hlth.Epidemiology and
Hlth.Economics of the Univ. of Liege, Liege, Belgzium; k INSERM UMR
1033 and Universite de Lyon, Ho^pital Edouard Herriot, Service de
Rhumatologie et Pathologie Osseuse, Lyon, France; {MRC Lifecourse
Epidemiology Unit, Southampton Gen. Hosp., Southampton, United
Kingdom
One of the most important issues in the studies of chondroprotection
is to be able to extrapolate a decrease in structural evolution into a
delay in knee surgeries such as joint replacement, as studies are
usually not long enough to provide this answer. Nevertheless, rapid
progressors on a short period of time (Group for the Respect of Ethics
and Excellence in Science (GREES) criteria) could help providing an
answer as these patients have been shown to be at higher risk of
surgeries.
Objective(s): The aim of this post hoc analysis is to describe the efﬁcacy
of Strontium Ranelate (SrRan) on rapid radiological progression, from
the ﬁrst year, in patients from SEKOIA study (randomised study with 3
years of treatment by 2 doses of SrRan versus placebo in knee
osteoarthritis).
Material and methods: 1683 patients suffering from symptomatic
primary knee osteoarthritis (Kellgren and Lawrence [KL] score of 2 or 3,
joint space width (JSW) of 2.5 to 5 mm and pain assessed on a visual
analogue scale of at least 40 mm) have been included and randomised
to receive SrRan 1 g/day, 2 g/day or placebo during 3 years. Knee X-rays
were performed yearly during 3 years, with a validated semi-automated
method of joint space narrowing (JSN) assessment. During the ﬁrst year,
radiological progressors (deﬁned as having a JSN  0,3 or  0,5 mm;
over the SDD), have been compared between groups using a Chi2 test in
the ITT population.
Results: ITT set included 1371 patients (82% of the randomized set;
445 patients in SrRan 1g group, 454 patients in SrRan 2g group and
472 patients in placebo group) with a mean age of 637 years, a mean
BMI of 305 kg/m2 and a mean JSW of 3.50.8 mm. 61% of patients
were KL II and 69% were female. A signiﬁcantly lower proportion of
patients in SrRan1g and 2g groups had radiological progression duringthe ﬁrst year compared to placebo: 12% and 13% versus 30%. The
estimate of the between groups difference E (SE) was -8.07 (2.42), 95%
CI [-12.81; -3.33] with p < 0.001 for SrRan 1g/d versus placebo and E
(SE) was -6.91 (2.45), 95% CI [-11.71; -2.10] with p ¼ 0.005 for SrRan
2g/d versus placebo. It corresponds to a decrease of the risk of rapid
progression by 40% and 35% in the SrRan 1g and 2g groups compared
to placebo
Conclusion: In patients suffering from primary knee OA, SrRan at the
dose of 1g or 2g/d decreases the number of rapid radiological pro-
gressors from the ﬁrst year of treatment suggesting that the beneﬁcial
structural effect could be clinically relevant.
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OLEUROPEIN OR RUTIN CONSUMPTION DECREASES THE
SPONTANEOUS DEVELOPMENT OF OA IN HARTLEY GUINEA PIG
M-N. Horcajada y, C. Sanchez z, F. Membrez y, P. Drion z, F. Comblain z,
E. Offord y, Y. Henrotin z. yNestle Res. Ctr., Lausanne, Switzerland; zUniv. of
Liege, Liege, Belgium
Purpose: Osteoarthritis is a high prevalence disease characterized by a
progressive loss of articular cartilage. Cartilage degradation is asso-
ciated with structural and metabolic changes in joint tissues such as
cartilage, subchondral bone and synovial membrane inﬂammation. One
reliable model to investigate the natural course of the disease and to
study the effects of treatments is Dunkin-Hartley guinea pigs devel-
oping spontaneous knee osteoarthritis which mimics the pathophy-
siological processes of human osteoarthritis. The potential protective
effects of three polyphenols found in olive oil (oleuropein) or fruits and
vegetables (rutin and curcumin) were assessed on this joint ageing and
osteoarthritis development model.
Methods: Sixty four-week old Dunkin-Hartley guinea pigs were random-
ized into four groups and received daily during 31 weeks either standard
guinea pig diet (control group) or a standard guinea pig diet enrichedwith
oleuropein (0.025 %), rutin (0.5%) or rutin/curcumin (0.5% / 0.25%) associ-
ation. Animals were weighed each week and blood samples taken every 6
weeksandat thetimeof euthanasia (week35).Biomarkersofosteoarthritis
(COLL2-1, COLL2-1NO2, Fib3-1, Fib3-2) as well as inﬂammation (PGE2)
were quantiﬁed in the serum. Histological assessments of knee cartilage
and synovial membrane were performed at week 35.
